FORM 10-QSB

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



(Mark One)

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934 
For the quarterly period ended December 31, 1995

                                       OR

[ ]  TRANSITION  REPORT  PURSUANT  TO SECTION  13 OR 15(d) OF THE  SECURITIES
     EXCHANGE ACT OF 1934
For the transition period from  _____________________ to _____________________

Commission file number                      1-6107

                                SKLAR CORPORATION
             (Exact name of registrant as specified in its charter)

           Pennsylvania                                44-0625447
  (State or other jurisdiction of             (I.R.S. Employer Identification
  incorporation or organization)                         Number)

889 S. Matlack Street, West Chester, Pennsylvania        19382
(Address of principal executive offices)               (Zip Code)

Issuer's telephone number         (610) 430-3200

     Check whether the issuer (l) has filed all reports  required to be filed by
Section 13 or 15(d) of the Securities  Exchange Act of 1934 during the preceding
12 months (or for such shorter  period that the  registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past
90 days.           Yes __X__       No _____

                APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                   PROCEEDINGS DURING THE PRECEDING FIVE YEARS

     Check whether the registrant filed all documents and reports required to be
filed by Section 12, 13 or 15(d) of the Exchange Act after the  distribution  of
securities under a plan confirmed by a court. Yes ________ No ________

                      APPLICABLE ONLY TO CORPORATE ISSUERS

     State the number of shares  outstanding of each of the issuer's  classes of
common equity, as of the latest practicable date.

              Class                           Outstanding at January 11, 1995
   (Common stock, $0.10 par value)                       1,237,711

Transitional Small Business Disclosure Format (Check one): Yes ____  No __X__


<PAGE>


                                SKLAR CORPORATION


                                      INDEX



                                                                        Page No.

Part I    Financial Information

          Balance Sheet -  December 31, 1995 .................................3

          Statement of Income -
               nine months ended December 31, 1995 and 1994 ..................4

          Statement of Cash Flows -
               nine months ended December 31, 1995 and 1994 ..................5

          Notes to condensed financial statements ........................6 - 9

          Management's Discussion and Analysis of Financial
               Condition and Results of Operations .....................10 - 11


Part II   Other Information

          Item 1    Legal Proceedings .......................................11

          Item 3    Defaults Upon Senior Securities .........................11


                                       2
<PAGE>


                                SKLAR CORPORATION
                                  BALANCE SHEET
                                   (Unaudited)
<TABLE>
<CAPTION>
ASSETS                                                                12/31/95
<S>                                                              <C>
CURRENT ASSETS:
     Cash                                                           $    14,486
     Accounts Receivable                                              1,460,093
     Inventories (Note 5)                                             2,819,925
     Prepaid Expenses                                                    33,676
                                                                    -----------
TOTAL CURRENT ASSETS                                                  4,328,180

EQUIPMENT AND IMPROVEMENTS (Note 6)                                     444,625
GOODWILL (Note 7)                                                       865,756
OTHER ASSETS                                                            349,472
                                                                    -----------
TOTAL ASSETS                                                        $ 5,988,033
                                                                    ===========

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
     Cash Overdraft                                                 $         0
     Short-term Bank Borrowings (Note 2)                              1,419,000
     Current Portion-Long-Term Debt                                     287,773
     Current Portion-Capital Lease Obligation                            19,854
     Trade Accounts Payable                                           1,550,365
     Accrued Expenses                                                   131,596
     Accrued Income Taxes                                                 2,985
                                                                    -----------
TOTAL CURRENT LIABILITIES                                             3,411,573

     Long-term Debt (Note 3)                                            523,422
     Long-term Capital Lease Obligation                                       0
     Other Liabilities                                                  122,549
                                                                    -----------
TOTAL LIABILITIES                                                     4,057,544
                                                                    -----------

CONTINGENCIES

STOCKHOLDERS' EQUITY (Note 9):
     Series A convertible preferred stock, par value
       $.01 per share, authorized, 10,000,000 shares;
       issued and outstanding 24,825 shares                                 248
     Series A subordinate convertible preferred stock,
       no par value, authorized 4,000 shares; issued
       and outstanding -0-                                                    0
     Common stock, par value $.10 per share,
        authorized, 1,500,000 shares; issued and
        outstanding, 1,237,711 shares                                   123,771
     Additional Paid-in Capital                                       2,106,482
     Deficit                                                           (300,012)
                                                                    -----------
                                                                      1,930,489
                                                                    -----------

TOTAL LIABILITIES & STOCKHOLDER'S EQUITY                            $ 5,988,033
                                                                    ===========
</TABLE>


                        See notes to financial statements

                                       3
<PAGE>


                                SKLAR CORPORATION
                              STATEMENTS OF INCOME
                                   AND DEFICIT
                                   (Unaudited)
<TABLE>
<CAPTION>
                                                     For the Nine Months Ended
                                                   12/31/95              12/31/94
<S>                                            <C>                    <C>
Revenues:
   Net Sales (Note 10)                           $ 7,074,783           $ 4,485,386


Cost and Expenses:
  Cost of Goods Sold                               3,779,634             2,166,243
  Selling, General and Administrative              3,008,564             2,098,972
  Interest                                           233,680               166,264
                                                 -----------           -----------

                                                   7,021,878             4,431,479
                                                 -----------           -----------

Income before taxes                                   52,905                53,907



Provisions for Income Taxes
  Currently Payable (Note 8)                          10,000                11,700
                                                 -----------           -----------

Net Income                                            42,905                42,207
                                                 -----------           -----------

Preferred Dividend Requirement (Note 9)              232,734               232,734
                                                 -----------           -----------

Loss Applicable to Common Shares                 $  (189,829)          $  (190,527)
                                                 -----------           -----------

Per Share Data:

Weighted Average Common Shares
  Outstanding                                      1,237,711             1,237,711
                                                 -----------           -----------

Loss Per Share (Note 11)                         $     (0.15)          $     (0.15)
                                                 ===========           ===========
</TABLE>




                        See notes to financial statements

                                       4
<PAGE>


                                SKLAR CORPORATION
                            STATEMENTS OF CASH FLOWS
                           INCREASE (DECREASE) IN CASH
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                                   For the Nine Months Ended
                                                               12/31/95              12/31/94
<S>                                                          <C>                  <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
     Net Income                                              $    42,905           $    42,207
     Adjustments to reconcile net income to
       net cash provided by operating activities:
         Depreciation and amortization                           521,766               212,126
         Provision for losses on
             accounts receivable                                  18,000                18,000

     Change in operating assets and liabilities:
         (Increase) in accounts receivable                      (305,795)             (100,530)
         (Increase) decrease in inventory                        190,858            (1,021,368)
         (Increase) decrease in prepaid expense                   (5,386)                5,622
         Increase (decrease) in accounts payable                (173,163)              329,602
         Increase (decrease) in accrued expenses                  35,482                (1,980)
         (Decrease) in income taxes payable                       (4,656)              (37,959)
                                                             -----------           -----------

              Total Adjustments                                  277,106              (596,487)
                                                             -----------           -----------
         Net cash provided by(used in)
              operating activities                               320,011              (554,280)
                                                             -----------           -----------

CASH FLOWS FROM INVESTING ACTIVITIES:
     Capital expenditures                                       (116,534)             (174,274)
     Principal payments received on note receivable                    0                60,000
     Intangible Assets                                          (135,974)              (62,042)
                                                             -----------           -----------
         Net cash used in investing activities                  (252,508)             (176,316)
                                                             -----------           -----------

CASH FLOWS FROM FINANCING ACTIVITIES:
     Net borrowings on line-of-credit                            134,000               144,000
     Net payments on capital lease (Note 12)                     (14,456)              (13,707)
     Net borrowings(payments) on long term debt                 (291,678)              563,788
                                                             -----------           -----------
         Net cash provided by(used in)
              financing activities                              (172,134)              694,081
                                                             -----------           -----------

NET (DECREASE) IN CASH                                          (104,631)              (36,515)
CASH BEGINNING OF PERIOD                                         119,117               (16,044)
                                                             -----------           -----------

CASH END OF THE PERIOD                                       $    14,486           $   (52,559)
                                                             ===========           ===========
</TABLE>


                        See notes to financial statements

                                       5
<PAGE>


                                SKLAR CORPORATION
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)


NOTE 1   MANAGEMENT'S REPRESENTATION

In the opinion of Management,  the unaudited  financial  statements  contain all
adjustments  necessary to present  fairly the financial  position as of December
31, 1995 and the results of operations and cash flows for the period then ended.

NOTE 2   SHORT-TERM BANK BORROWINGS

On November  18,  1994 the Company  entered  into an amended  revolving  line of
credit agreement for $2,200,000  collateralized  by the sum of 80% of qualifying
accounts  receivable  plus 45% of  inventories.  Borrowings  based  on  eligible
inventories  have  a  fluctuating  maximum  allowable  balance  up to  $800,000.
Qualifying  accounts  receivable  and inventory used as a basis for the December
31, 1995 borrowing totaled  $1,852,000.  Unused available credit at December 31,
1995 was  $433,000.  The amount of available  credit line is dependent  upon the
balance of qualifying accounts receivable and inventory and is therefore subject
to change.

Borrowings from this line bear interest at the Bank's  National  Commercial Rate
(BNCR) plus 2.25% (two and one-quarter  percent).  At December 31, 1995 the BNCR
was 8.50%.  The interest expense on short-term bank borrowings for 1995 and 1994
amounted to $123,770 and $90,531, respectively.

The terms of the  borrowing  agreement  state that the Company may not,  without
prior consent of the lender,  declare or pay any  dividends or incur  additional
debt or  obligations.  The  Company's  President,  Mr.  Don  Taylor,  personally
guaranteed  all  obligations  under  this  agreement  secured  by a lien  on his
personal assets and his common and preferred shares of the Company's stock.

On May 20,  1994 the Company  entered  into  agreements  with  Meridian  Bank to
restructure then existing financing agreements.  That amended line of credit had
a maximum principal amount of $1,600,000,  replacing the former $2,000,000.  The
rate  of  interest  on  this  line  was   calculated  at  the  BNCR  plus  2.5%.
Simultaneously, the Company negotiated a three year term loan of $400,000 at the
same interest rate, of which  principal of $11,111 and accrued  interest will be
paid in 36 monthly  installments  commencing June 1, 1994 and due in full May 1,
1997.

NOTE 3   LONG-TERM DEBT

On November 18, 1994,  coincident with the purchase of inventory from the Herwig
Division  of the  General  Medical  Corporation,  the  Company  entered  into an
additional short term borrowing  agreement with Meridian Bank which, on December
28, 1994,  was  converted to a 60 month  borrowing  arrangement.  The  long-term
agreement  with Meridian  Bank,  guaranteed by the United States Small  Business
Administration  (SBA), provided for the Company to borrow $700,000 with interest
at New York's Prime Rate plus 2.25% payable monthly.  The principal is repayable
in monthly  amounts  beginning in March 1995. The first three monthly  principal
payments were $50,000 and the remainder are $10,000 through December, 1999. This
loan is secured by the Herwig  inventory and all of the Company's other tangible
and intangible assets.

                                       6
<PAGE>

                                SKLAR CORPORATION
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)

NOTE 3   LONG-TERM DEBT, (continued)

Additional monthly principal payments are required if the outstanding  principal
on the loan exceeds 50% of the Herwig  inventory  value,  including  replacement
inventory purchased in the ordinary course of business. The prime rate was 8.50%
at December 31, 1995.

On May 20, 1994 the Company  negotiated a three year term loan of $400,000  with
Meridian Bank as described in Note 2 above as part of a general restructuring of
existing financing agreements.

The contract  under which Dental  Corporation  of America (DCA) was acquired was
renegotiated  in April 1992.  The  renegotiated  contract,  among other  things,
changed  the  payment  terms from three  fixed  $100,000  annual  payments  plus
interest and  royalties  based upon future sales to a fixed  monthly  payment of
$12,000 for one year  commencing  April 1, 1992 followed by a monthly payment of
$5,000 for six years commencing April 1, 1993. The gross payments and associated
liability under the new agreement are  substantially  the same as to those which
were recorded,  including  interest,  upon the acquisition of DCA.  Accordingly,
there has been no change to the financial  statements  in  connection  with this
renegotiation.  The new agreement did however  change the aggregate  prospective
maturities.

NOTE 4   BUSINESS OPERATIONS

The Company  imports and  distributes  under the Sklar,  Misdom-Frank  and other
trademarks hand-held,  non-electronic  instruments for the surgical,  dental and
veterinary fields.

On November 18, 1994 the Company  purchased the inventory of the Herwig Division
of the General Medical Corporation (GMC) for $871,922. In addition,  and as part
of the  purchase  agreement,  the Company  entered  into a  marketing  agreement
whereby the Company committed to supplying GMC with its medical instrument needs
for its customers for a fifty month term.  GMC is under no obligation to buy any
items  from the  Company  during  the term of the  agreement,  but if items  are
purchased by GMC the Company is obligated  to make certain  marketing  incentive
payments.

NOTE 5   INVENTORIES

Inventories  are  stated at the lower of cost  (first-in,  first-out  method) or
market.

NOTE 6   EQUIPMENT AND IMPROVEMENTS

Equipment and improvements are stated at cost less accumulated  depreciation and
amortization.  Depreciation  and  amortization  are  provided  generally  on the
straight-line  method over the useful lives of the assets which are estimated to
be three to ten years for  equipment and the shorter of the life of the lease or
the life of the asset for leasehold improvements.

                                       7
<PAGE>


                                SKLAR CORPORATION
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)


NOTE 7   GOODWILL AND CATALOG DEVELOPMENT COSTS

Goodwill is amortized over twenty years, and catalog development costs are being
amortized  over at various  schedules  ranging from 1 1/2 - 5 years for the nine
month period ended  December 31, 1995.  For the nine month period ended December
31, 1994 goodwill and catalog  development costs were amortized over forty years
and 1 1/2 - 7 years, respectively.

NOTE 8   INCOME TAXES

Income taxes  represent  the State tax due.  Federal  income  taxes  payable are
offset by net operating loss  carryforwards and goodwill is reduced  accordingly
to reflect the utilization of the loss carryforwards.  No tax loss carryforwards
exist to offset state income tax payable.

As a  result  of the  merger  of  Medco  Jewelry  Corporation  and  Misdom-Frank
Corporation,  management  believes  there  may be  federal  net  operating  loss
carry-forwards available to Medco Jewelry Corporation at the date of merger that
have transferred to Sklar Corporation.  Such loss  carry-forwards and additional
post-merger operating losses totaling approximately $3,850,000,  which expire in
1995  ($1,596,000),  1997  ($244,000),  1998  ($974,000),  1999 ($50,000),  2000
($14,000),  2001 ($461,000),  and 2002  ($511,000),  are available as deductions
from federal taxable income of future years.

NOTE 9   STOCKHOLDERS' EQUITY

As of December 31, 1995,  of the  1,500,000  shares of Common Stock  authorized,
1,237,711 are outstanding.  Of the Series A Convertible  Preferred Stock, 24,825
shares are authorized and outstanding.

The Series A  Convertible  Preferred  Stock may be redeemed by the Company after
March 1,  1986 at a price of $100 per  share and is  entitled  to a  liquidation
preference  of $100 per share plus  cumulative  dividends.  Annual  dividends of
$12.50 per share accrue cumulatively on the Series A Convertible Preferred Stock
commencing on July 1, 1984,  payable on June 30 of each year commencing June 30,
1985. No dividends have been declared in any years through 1995.

NOTE 10   SALES

A sale is recorded when title to the product passes to the customer.

NOTE 11   NET LOSS PER SHARE

Net loss per share is  computed by dividing  the net loss  applicable  to common
shares by the  weighted  average  number of shares of Common  Stock  outstanding
after giving effect to the ratably  accrued  preferred  dividend.  No effect has
been given to Common Stock equivalent shares as such would be anti-dilutive.

                                       8
<PAGE>


                                SKLAR CORPORATION
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)


NOTE 12   CASH FLOW INFORMATION

For purposes of the statement of cash flows, the Company  considers cash in bank
and on hand as cash equivalents.

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

Interest paid  amounted to $234,540 in the nine months ended  December 31, 1995,
and $137,448 in the nine months ended December 31, 1994.

Income  taxes paid  amounted to $14,479 in the nine months  ended  December  31,
1995, and $32,939 in the nine months ended December 31, 1994.

                                       9
<PAGE>


                                SKLAR CORPORATION
                       MANAGEMENT DISCUSSION AND ANALYSIS


The following  discussion and analysis  provides  information  which  management
believes is relevant to an assessment and understanding of the Company's results
of  operations  and  financial  condition.  The  discussion  should  be  read in
conjunction with the financial  statements and notes thereto appearing elsewhere
herein.

RESULTS OF OPERATIONS

The following table sets forth, for the periods indicated, the percentage of net
sales for certain items in the Company's Statements of Income for each period:

Income and Expense Items as Percentage of
Net Sales for the Quarter ended December 31

                                1995             1994

Net Sales                       100.0%          100.0%
Cost of Sales                    53.4            50.5
Gross Profit                     46.6            49.5
Selling, General and
  Admin. Expenses                42.5            44.6
Income (Loss) Before
  Interest & Taxes                4.1             4.9
Interest Expense                  3.3             3.5
Income Before
  Income Taxes                    0.7             1.3
Net Income                        0.6             1.2


SALES

For the nine month  period ended  December  31, 1995  compared to the nine month
period ended December 31, 1994, sales were up $2,589,397 or 57.7%. This increase
reflects the impact of the marketing  agreement  entered into with the Company's
major customer and the success of the Company's  approach to build sales through
an emphasis on marketing and advertising.

COST OF SALES

Cost of sales as a percentage of sales  increased 2.9% for the nine month period
December 31, 1995  compared to the nine month  period  ended  December 31, 1994.
This increase  reflects the higher cost of products as a result of a weakened US
dollar on foreign exchange rates and a diminishing profit margin as a percent of
sales due to increasing competitiveness in the health care industry.  Management
expects the business to continue to show a lower  profit  margin as a percent of
sales in future periods.

                                       10
<PAGE>


                                SKLAR CORPORATION
                       MANAGEMENT DISCUSSION AND ANALYSIS


SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

Selling,  General and  Administrative  expenses  for the nine month period ended
December  31, 1995 have  increased  $909,592 or 43.3% from the nine month period
ended December 31, 1994. The increase in these  expenditures  is a result of the
Company's  commitment to an increased  marketing and advertising  effort and the
resulting  increased  personnel and advertising  costs.  Increased  amortization
rates for goodwill and catalogs has also contributed to this higher amount.  The
increased sales volume has also required certain of these increases.  Management
expects to continue this level of expenditure in future periods.

INTEREST

Interest  costs  increased  $67,416  or 40.5% for the nine  month  period  ended
December 31, 1995 compared to the nine month period ended  December 31, 1994 due
to increased borrowing levels.  Borrowing increased primarily as a result of the
financing  necessary to purchase the inventory of the Herwig Division of General
Medical Corporation and finance the resulting increased sales volume.

INCOME TAXES

Federal  income tax  expense is reduced  in both  periods by the  available  net
operating loss carryforwards. Income tax expense represents state income tax.

LIQUIDITY AND CAPITAL RESOURCES

The  Company's  $2,200,000  revolving  line  of  credit  with  Meridian  Bank is
considered  adequate to meet the  financing  requirements  of the Company in the
foreseeable future.


                           PART II - OTHER INFORMATION


ITEM 1   LEGAL MATTERS

 (A) The  Company  has  filed  suit  against  the  former  principal  of DCA for
violating  terms of a non-compete  agreement  signed as part of a  re-negotiated
settlement for the purchase of DCA. This suit will seek the return of all monies
paid to the former principal to date. This case is currently in the pleading and
discovery  stage,  therefore,  no assessment of the outcome of the case has been
made by legal counsel.

ITEM 3   DEFAULTS UPON SENIOR SECURITIES

As reported in  registrant's  form 10-Q for the quarter ended  December 31, 1985
and as further discussed in Note 9 to the financial  statements,  the registrant
did not  declare a dividend on its  cumulative  Series A  Convertible  Preferred
Stock in any year through 1995.

                                       11

<PAGE>


     PURSUANT TO THE  REQUIREMENTS  OF THE SECURITIES  EXCHANGE ACT OF 1934, THE
REGISTRANT  HAS DULY  CAUSED  THE  REPORT  TO BE  SIGNED  ON ITS  BEHALF  BY THE
UNDERSIGNED THEREUNTO DULY AUTHORIZED.



SKLAR CORPORATION








DON TAYLOR
PRESIDENT

January 30, 1996